[1] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2016). DHA and improvement of memory function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 14(5), e04455. https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2016.4455
[2] Guesnet, P., & Alessandri, J.-M. (2011). Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)—Implications for dietary recommendations. Biochimie, 93(1), 7–12. https://www.sciencedirect.com/science/article/abs/pii/S0300908410001823?via%3Dihub
[3] Stonehouse, W., Conlon, C. A., Podd, J., Hill, S. R., Minihane, A. M., Haskell, C., & Kennedy, D. (2013). DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. The American Journal of Clinical Nutrition, 97(5), 1134–1143 https://www.sciencedirect.com/science/article/pii/S0002916523055235?via%3Dihub
[4] Leckie, R. L., Lehman, D. E., Gianaros, P. J., Erickson, K. I., Sereika, S. M., Kuan, D. C. H., Manuck, S. B., Ryan, C. M., Yao, J. K., & Muldoon, M. F. (2020). The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: A randomized clinical trial. Psychological Medicine, 50(14), 2425–2434. https://www.cambridge.org/core/journals/psychological-medicine/article/abs/effects-of-omega3-fatty-acids-on-neuropsychological-functioning-and-brain-morphology-in-midlife-adults-a-randomized-clinical-trial/7318B460142C6F72720F2AB6A0F03B6B
[5] Hashimoto, M., & Hossain, S. (2011). Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer’s disease. Journal of Pharmacological Sciences, 116(2), 150–162. https://www.jstage.jst.go.jp/article/jphs/116/2/116_10R33FM/_article
[6] Yurko-Mauro, K., Alexander, D. D., & Van Elswyk, M. E. (2015). Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PloS One, 10(3), e0120391. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120391
[7] Murphy, R. A., Devarshi, P. P., Ekimura, S., Marshall, K., & Mitmesser, S. H. (2021). Long-chain omega-3 fatty acid serum concentrations across life stages in the USA: An analysis of NHANES 2011–2012. BMJ Open, 11(5), e043301. https://bmjopen.bmj.com/content/11/5/e043301
[8] Derbyshire, E. (2019). Oily Fish and Omega-3s Across the Life Stages: A Focus on Intakes and Future Directions. Frontiers in Nutrition, 6, 165. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2019.00165/full
[9] European Food Safety Authority. (2009). DHA and support of the cognitive development of the unborn child and breastfed infant—Scientific substantiation of a health claim related to DHA and support of the cognitive development of the unborn child and breastfed infant pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 7(4), 1007. https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2009.1007
[10] European Food Safety Authority. (2011). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega-3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti-inflammatory action” (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4), 2078. https://www.efsa.europa.eu/en/efsajournal/pub/2078
[11] Horrocks, L. A., & Yeo, Y. K. (1999). Health benefits of docosahexaenoic acid (DHA). Pharmacological Research, 40(3), 211–225. https://www.sciencedirect.com/science/article/abs/pii/S1043661899904954?via%3Dihub
[12] Cao, D., Kevala, K., Kim, J., Moon, H.-S., Jun, S. B., Lovinger, D., & Kim, H.-Y. (2009). Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. Journal of Neurochemistry, 111(2), 510. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1471-4159.2009.06335.x
[13] Cao, D., Kevala, K., Kim, J., Moon, H.-S., Jun, S. B., Lovinger, D., & Kim, H.-Y. (2009). Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. Journal of Neurochemistry, 111(2), 510. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1471-4159.2009.06335.x
[14] Dagai, L., Peri-Naor, R., & Birk, R. Z. (2009). Docosahexaenoic Acid Significantly Stimulates Immediate Early Response Genes and Neurite Outgrowth. Neurochemical Research, 34(5), 867–875. https://link.springer.com/article/10.1007/s11064-008-9845-z
[15] Blinkouskaya, Y., Caçoilo, A., Gollamudi, T., Jalalian, S., & Weickenmeier, J. (2021). Brain aging mechanisms with mechanical manifestations. Mechanisms of Ageing and Development, 200, 111575. https://www.sciencedirect.com/science/article/pii/S0047637421001470?via%3Dihub
[16] Pickersgill, J. W., Turco, C. V., Ramdeo, K., Rehsi, R. S., Foglia, S. D., & Nelson, A. J. (2022). The Combined Influences of Exercise, Diet and Sleep on Neuroplasticity. Frontiers in Psychology, 13, 831819. https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2022.831819/full
[17] von Schacky, C. (2021). Importance of EPA and DHA Blood Levels in Brain Structure and Function. Nutrients, 13(4), 1074. https://www.mdpi.com/2072-6643/13/4/1074
[18] European Food Safety Authority. (2011). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega-3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti-inflammatory action” (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4), 2078. https://www.efsa.europa.eu/en/efsajournal/pub/2078
[19] European Food Safety Authority. (2011). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega-3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti-inflammatory action” (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4), 2078. https://www.efsa.europa.eu/en/efsajournal/pub/2078
[20] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2010). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10), 1734. https://www.efsa.europa.eu/en/efsajournal/pub/1734
ᶧ beneficial effect is obtained with a daily intake of 250 mg
ᶧᶧ beneficial effect obtained with a daily intake of 200mg of DHA in addition to the recommended daily intake of omega-3 fatty acids of 250mg combined DHA & EPA
ᶧᶧᶧ the beneficial effect is obtained with a daily intake of 3 grams of omega 3 fatty acids combined of DHA and EPA
ᶧᶧᶧᶧthe beneficial effect is obtained with a daily intake of 250 mg of EPA and DHA.
ᶧᶧᶧᶧᶧbeneficial effect is obtained with a daily intake of 2 g of DHA